Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1998-6-4
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0003-9926
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
941-2
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9588426-Alzheimer Disease,
pubmed-meshheading:9588426-Cholinesterase Inhibitors,
pubmed-meshheading:9588426-Humans,
pubmed-meshheading:9588426-Indans,
pubmed-meshheading:9588426-Multicenter Studies as Topic,
pubmed-meshheading:9588426-Piperidines,
pubmed-meshheading:9588426-Randomized Controlled Trials as Topic,
pubmed-meshheading:9588426-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
New drug treatments for Alzheimer disease.
|
pubmed:publicationType |
Editorial,
Comment
|